Lucas Wong

Safety and Efficacy of Oxaliplatin and Fluoropyrimidine Regimens With or Without Bevacizumab As First-Line Treatment of Metastatic Colorectal Cancer: Results of the TREE Study

Howard S. Höchster, Lowell L. Hart, Ramesh K. Ramanathan et al. · Journal of Clinical Oncology · 2008 · 623 citations

Medicine, Oncology, Pharmacotherapy +13

Peroxisome Proliferator-activated Receptor γ Activation Can Regulate β-Catenin Levels via a Proteasome-mediated and Adenomatous Polyposis Coli-independent Pathway

Chandan Sharma, Anamika Pradeep, Lucas Wong et al. · Journal of Biological Chemistry · 2004 · 127 citations · Full text

Life Sciences, Biochemistry, Pharmacology +14

Phase 2, multicenter, open‐label study of tigatuzumab (CS‐1008), a humanized monoclonal antibody targeting death receptor 5, in combination with gemcitabine in chemotherapy‐naive patients with unresectable or metastatic pancreatic cancer

Andres Forero‐Torres, Jeffrey R. Infante, David Waterhouse et al. · Cancer Medicine · 2013 · 90 citations · Full text

Medicine, Oncology, Pharmacology +17

Glycogen Synthase Kinase-3β Induces Neuronal Cell Death via Direct Phosphorylation of Mixed Lineage Kinase 3

Rajakishore Mishra, Manoj Kumar Barthwal, Gautam Sondarva et al. · Journal of Biological Chemistry · 2007 · 78 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Phase I Safety and Pharmacokinetic Study of Bavituximab, a Chimeric Phosphatidylserine-Targeting Monoclonal Antibody, in Patients with Advanced Solid Tumors

David E. Gerber, Alison Stopeck, Lucas Wong et al. · Clinical Cancer Research · 2011 · 73 citations

Pharmacy, Oncology, Pharmacology +17